FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells

Zuhal Hamurcu; Ahmed Ashour; Nermin Kahraman; Bulent Ozpolat

doi:10.18632/oncotarget.7672

FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells

Oncotarget ◽

10.18632/oncotarget.7672 ◽

2016 ◽

Vol 7 (13) ◽

pp. 16619-16635 ◽

Cited By ~ 41

Author(s):

Zuhal Hamurcu ◽

Ahmed Ashour ◽

Nermin Kahraman ◽

Bulent Ozpolat

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Elongation Factor ◽

Elongation Factor 2 ◽

Eukaryotic Elongation Factor 2 ◽

Eukaryotic Elongation Factor

Abstract 3249: Thymoquinone inhibits elongation factor 2 kinase signaling axis by inducing tumor suppressor miR-603 in triple negative breast cancer cells

10.1158/1538-7445.am2017-3249 ◽

2017 ◽

Author(s):

Nashwa N. Kabil ◽

Recep Bayraktar ◽

Nermin Kahraman ◽

Bulent Ozpolat

Keyword(s):

Breast Cancer ◽

Tumor Suppressor ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Elongation Factor ◽

Kinase Signaling ◽

Elongation Factor 2 ◽

Signaling Axis

Eukaryotic elongation factor-2 kinase mediated autophagy as potential therapeutic target for paclitaxel-resistant triple-negative breast cancer

The Breast ◽

10.1016/s0960-9776(19)30130-4 ◽

2019 ◽

Vol 44 ◽

pp. S25

Author(s):

S. Chen ◽

R.-X. Wang ◽

Z.-M. Shao

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Therapeutic Target ◽

Triple Negative ◽

Elongation Factor ◽

Potential Therapeutic Target ◽

Elongation Factor 2 ◽

Eukaryotic Elongation Factor 2 ◽

Eukaryotic Elongation Factor

Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy

European Journal of Medicinal Chemistry ◽

10.1016/j.ejmech.2017.12.046 ◽

2018 ◽

Vol 144 ◽

pp. 517-528 ◽

Cited By ~ 14

Author(s):

Zhaoping Pan ◽

Yujuan Chen ◽

Jingyan Liu ◽

Qinglin Jiang ◽

Shengyong Yang ◽

...

Keyword(s):

Breast Cancer ◽

Breast Cancer Cells ◽

Elongation Factor ◽

Biological Evaluation ◽

Design Synthesis ◽

Elongation Factor 2 ◽

Eukaryotic Elongation Factor 2 ◽

Eukaryotic Elongation Factor ◽

Dual Inhibitors ◽

Synthesis And Biological Evaluation

Faculty Opinions recommendation of Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737060005.793568589 ◽

2019 ◽

Author(s):

Junjie Chen

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative

MiRNAs-181a/b as Predictive biomarkers for olaparib sensitivity in triple-negative breast cancer cells.

Biochemistry Letters ◽

10.21608/blj.2017.47612 ◽

2017 ◽

Vol 12 (1) ◽

pp. 221-229

Author(s):

Abeer M. Ashmawy ◽

Mona A. Sheta ◽

Faten Zahran ◽

Abdel Hady A. Abdel Wahab

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Predictive Biomarkers

microRNA-506-3p suppresses the proliferation of triple negative breast cancer cells via targeting SNAI2

Molecular & Cellular Toxicology ◽

10.1007/s13273-021-00160-7 ◽

2021 ◽

Vol 17 (4) ◽

pp. 513-522

Author(s):

Xuye Zhao ◽

Xiangdong Bai ◽

Weina Li ◽

Xuezhen Gao ◽

Xiaoli Wang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative

Fluorouracil uptake in triple‐negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2

Biopharmaceutics & Drug Disposition ◽

10.1002/bdd.2261 ◽

2021 ◽

Author(s):

Saki Noguchi ◽

Akinori Takagi ◽

Takahiro Tanaka ◽

Yu Takahashi ◽

Xiaole Pan ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Nucleoside Transporters ◽

Equilibrative Nucleoside Transporters ◽

Negligible Contribution

Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells

Breast Cancer Research and Treatment ◽

10.1007/s10549-021-06255-y ◽

2021 ◽

Author(s):

Rania Harati ◽

Aloïse Mabondzo ◽

Abdelaziz Tlili ◽

Ghalia Khoder ◽

Mona Mahfood ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Cyclooxygenase 2 ◽

Synergistic Inhibition

Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts

Nanomedicine Nanotechnology Biology and Medicine ◽

10.1016/j.nano.2021.102383 ◽

2021 ◽

Vol 34 ◽

pp. 102383

Author(s):

Karen M. Bussard ◽

Christopher M. Gigliotti ◽

Bernadette M. Adair ◽

Jenna M. Snyder ◽

Nicholas T. Gigliotti ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Metastatic Breast ◽

Calcium Phosphosilicate ◽

Preferential Uptake

MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene

Clinical & Translational Oncology ◽

10.1007/s12094-021-02672-z ◽

2021 ◽

Author(s):

Y. L. Wang ◽

R. H. Liang ◽

C. Y. Wang ◽

R. P. Zhang ◽

S. Y. Wu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Triple Negative Breast Cancer ◽

Breast Cancer Cells ◽

Triple Negative ◽

Epithelial Mesenchymal Transition ◽

Down Regulation ◽

Mesenchymal Transition